Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
17480-69-2C[C@H](NCc1ccccc1)c1ccccc1ZYZHMSJNPCYUTB-ZDUSSCGKSA-N17480-69-2DTXSID90361450Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (97.8%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden(S)-()-N-Benzyl-α-methylbenzylamine can be used:In one of the key synthetic steps for the preparation of a cardioprotective drug named CP-060S.To prepare (1S,2S,3S,5R)-tert-butyl 3-[benzyl((S)-1-phenylethyl)amino]-6,6-dimethylbicyclo[3.1.1]heptane-2-carboxylate, an intermediate used to synthesize pinane-based β- and γ-amino acids.To prepare urea derivatives as potent antimicrobial agents.
Wird geladen…